Naloxone HCL 10 vials
$210.00
Naloxone HCL 10 vials Injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression
Naloxone HCL 10 vials Injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression https://powerhorsevet.com
Naloxone HCL 10 vials – Injection USP, NARCAN.
Single Dose Vial, Glass Fliptop Vial
Naloxone HCL 10 vials Injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including propoxyphene, methadone, and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol and cyclazocine.Package Quantity: 10/Pkg
Strength: 0.4 mg/ml Strength
Generic Name: Naloxone HCL 10 vials Injection, USP
Total Volume: 1 ml
Compare To: Narcan
Container Type: Single Dose Vial, Glass Fliptop Vial
Non-DEHP: Non-DEHP
Cap Color: Orange https://powerhorsevet.com/Naloxone HCL 10 vials – Injection USP, NARCAN.
Single Dose Vial, Glass Fliptop Vial
Naloxone HCL 10 vials Injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including propoxyphene, methadone, and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol and cyclazocine.
Package Quantity: 10/Pkg
Strength: 0.4 mg/ml Strength
Generic Name: 10 vials Injection, USP
Total Volume: 1 ml
Compare To: Narcan
Container Type: Single Dose Vial, Glass Fliptop Vial
Non-DEHP: Non-DEHP
Cap Color: Orange – Injection USP, NARCAN.
Single Dose Vial, Glass Fliptop Vial
10 vials Injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including propoxyphene, methadone, and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol and cyclazocine.
Package Quantity: 10/Pkg
Strength: 0.4 mg/ml Strength
Generic Name: Naloxone HCL 10 vials Injection, USP
Total Volume: 1 ml
Compare To: Narcan
Container Type: Single Dose Vial, Glass Fliptop Vial
Non-DEHP: Non-DEHP
Cap Color: Orange
Naloxone HCL 10 vials – Injection USP, NARCAN.
Single Dose Vial, Glass Fliptop Vial
Naloxone HCL 10 vials Injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including propoxyphene, methadone, and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol and
You must be logged in to post a review.
Related products
-
A180 100ML
$120.00Add to cartDescription
A180 100ML In cattle: Treatment of bovine respiratory illness caused by Mannheimia haemolytica, Pasteurella multocida and Histophilus somni sensitive to danofloxacin. A180 100ML For the treatment of acute bovine mastitis caused by Escherichia coli sensitive to danofloxacin. In neo-natal calves: Treatment of enteric infections caused by Escherichia coli sensitive to danofloxacinVM 42058/4000
Vet A180 (Canada)
Print Share
A180 (Canada)
This page contains information on A180 for veterinary use.
The information provided typically includes the following:
A180 Indications
Warnings and cautions for A180
Direction and dosage information for A180
A180
This treatment applies to the following species:
Beef Cattledanofloxacin mesylate sterile injectable solution
Veterinary Use Only
Description
A180 Injectable Solution is a sterile solution containing danofloxacin mesylate, a synthetic fluoroquinolone antimicrobial agent. Danofloxacin mesylate is the non-proprietary designationFigure 1. The chemical structure of danofloxacin mesylate
Each mL contains 180 mg of danofloxacin (as danofloxacin mesylate) and 2.5 mg phenol as the preservative.
A180 Indications
For the treatment of bovine respiratory disease associated with Mannheimia haemolytica and Pasteurella multocida.Dosage and Administration
Care should be taken to dose accurately. Administered dose volume should not exceed 15 mL per injection site.Single-Dose Therapy: Administer subcutaneously at 8 mg/kg of body weightas a one-time injection,
Multi-Day Therapy: Administer subcutaneously at 6 mg/kg of body weight with this treatment repeated once approximately 48 hours following the first injection
In cattle: Treatment of bovine respiratory disease caused by Mannheimia haemolytica, Pasteurella multocida and Histophilus somni sensitive to danofloxacin. For the treatment of acute bovine mastitis caused by Escherichia coli sensitive to danofloxacin.
In neo-natal calves: Treatment of enteric infections caused by Escherichia coli sensitive to danofloxacinIn cattle: Treatment of bovine respiratory disease caused by Mannheimia haemolytica, Pasteurella multocida and Histophilus somni sensitive to danofloxacin. For the treatment of acute bovine mastitis caused by Escherichia coli sensitive to danofloxacin.
In neo-natal calves: Treatment of enteric infections caused by Escherichia coli sensitive to danofloxacinIn cattle: Treatment of bovine respiratory disease caused by Mannheimia haemolytica, Pasteurella multocida and Histophilus somni sensitive to danofloxacin. For the treatment of acute bovine mastitis caused by Escherichia coli sensitive to danofloxacin.
In neo-natal calves: Treatment of enteric infections caused by Escherichia coli sensitive to danofloxacinA180 100ML A180 100ML A180 100ML A180 100ML A180 100ML A180 100ML A180 100ML A180 100ML A180 100ML A180 100ML A180 100ML
-
tussionex cough syrup
$220.00Add to carttussionex cough syrup is Pennkinetic Extended-Release Suspension is a prescription medicine used to treat cough and upper respiratory symptoms you may have with allergies or a cold . TUSSIONEX Pennkinetic Extended-Release Suspension is for adults and children 6 years and older. This combination product is used to treat coughs and other symptoms caused by the common cold …
Reviews
There are no reviews yet.